K042040

Substantially Equivalent

TRIACTIV SYSTEM

Applicant: Kensey Nash Corp.
Product code: NFA
Advisory panel: Cardiovascular
Date received: 2004-07-29
Decision date: 2005-03-23
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Exton, PA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.